Examining the Effects of Processed Music on Chronic Pain
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03083977 |
Recruitment Status :
Terminated
(pandemic related difficulties for recruitment)
First Posted : March 20, 2017
Last Update Posted : March 7, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Chronic pain is a common ailment in aging populations and often co-occurs with altered regulation of the autonomic nervous system. Nociceptive pathways (i.e., those that transmit pain signals) are integrated with autonomic circuits throughout the body and therapies that are successful in reducing pain concurrently alter autonomic functions, even when they are not directly designed to do so. It is possible that interventions that target the autonomic circuits that regulate pain responses may help reduce pain in chronic pain sufferers. The proposed study will examine whether an intervention that targets the autonomic nervous system via filtered music can reduce pain, a hypothesis derived from the Polyvagal Theory.
The Polyvagal Theory describes how function and structure of the vertebrate autonomic nervous system changed during evolution. The theory is named for the vagus, a major cranial nerve that regulates bodily state. An evolutionary "old" branch of this nerve innervates structures below the diaphragm and its dysfunction is linked to lower body organ and tissue pain. Regulation of the vagus nerve is linked with specific auditory cues based on our evolutionary heritage and the physics of the middle ear. This study is designed to test whether processed music designed to stimulate vagal function can decrease chronic pain. The Listening Project Protocol, the processed music used in this intervention, has previously been shown to effectively stimulate the function of the vagus nerve (see stimulus description below).
Specific Aims:
Aim I: To examine whether The Listening Project Protocol, a non-invasive audio intervention, can be effective for reducing chronic pain in a sample of older adults.
Hypothesis: Five 1-hour sessions of the Listening Project Protocol will reduce pain
Aim II: To examine whether increased regulation via the autonomic nervous system accounts for the decrease in pain if the intervention is successful.
Hypothesis: Pain reduction will coincide with improved autonomic function by the myelinated vagus nerve (measured by respiratory sinus arrhythmia, see below) as well as decrease in the reactivity of autonomic functions in everyday experiences (measured by the Body Perception Questionnaire, see below)
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pain | Other: Safe and Sound Protocol | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 8 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Examining the Effects of Processed Music on Chronic Pain |
Actual Study Start Date : | June 22, 2017 |
Actual Primary Completion Date : | August 28, 2019 |
Actual Study Completion Date : | August 28, 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention group
This group will listen to 1 hour of processed music (Safe and Sound Protocol) for 5 days
|
Other: Safe and Sound Protocol
The intervention features music processed based on the resonating frequencies of the middle ear |
- Pain intensity [ Time Frame: Change over 1 week ]Change in intensity of pain from pre-assessment to post-assessment, measured by the Brief Pain Inventory Short Form
- Pain experience [ Time Frame: Change over 1 week ]Change in experience of pain from pre-assessment to post-assessment, measured by the McGill Pain Questionnaire Short Form
- Autonomic Function [ Time Frame: Change over 1 week ]Amplitude of respiratory sinus arrhythmia (RSA), a measure of myelinated vagal effects on the heart
- Body perception [ Time Frame: Change over 1 week ]Autonomically-mediated body perception, measured by the Body Perception Questionnaire Short Form
- Auditory processing [ Time Frame: Change over 1 week ]Auditory speech processing measured by ability to extract speech from background noise and understand speech with frequencies removed; measured by the SCAN Test for Auditory Processing Disorders (Keith, 2000)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Participants must self-report as suffering from chronic pain
Exclusion Criteria:
- Individuals who do not read or speak proficient English
- Individuals with substantial, uncorrected hearing loss

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03083977
United States, Indiana | |
Meadowood Retirement Community | |
Bloomington, Indiana, United States, 47408 |
Principal Investigator: | Stephen Porges, PhD | Indiana University | |
Study Chair: | Peter Miksza, PhD | Indiana University | |
Study Chair: | Hannah Fidler | Indiana University | |
Study Chair: | Jacek Kolacz, PhD | Indiana University |
Responsible Party: | Stephen Porges, Distinguished University Scientist, Indiana University |
ClinicalTrials.gov Identifier: | NCT03083977 |
Other Study ID Numbers: |
1702490842 |
First Posted: | March 20, 2017 Key Record Dates |
Last Update Posted: | March 7, 2022 |
Last Verified: | February 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Chronic Pain Pain Neurologic Manifestations |